Overview publication

TitleRenal Impairment, Cardiovascular Disease, and the Short-Term Efficacy and Safety of PCSK9 Targeted by Inclisiran.
DateJanuary 1st, 2020
Issue nameMayo Clinic proceedings
Issue numberv95.1:12-14
DOI10.1016/j.mayocp.2019.11.010
AuthorsZijlstra LE, Trompet S, Mooijaart SP, van Buren M & Jukema JW
Read Read publication